RCOM RADIOLOGICAL CASE OF THE MONTH

Applied Radiology — Vol. 33 , Issue 3 , pp. 48 -49

DOI: 10.37549/AR1233

Published: March 1, 2004

Iman Naseri, MD, Ranjiv Saini, MD, Cynthia T. Welsh, MD

Categories

article Article ar

CASE SUMMARY

A 10-year-old white boy presented with a 2-year history of staring spells and automatisms followed by 10 to 20 minutes of sleep. He had an unremarkable medical history other than an existing seizure disorder. Medications included divalproex sodium (125 mg, 3 tablets po TID) and levetiracetam (250 mg, 2 tablets po TID). Family history was negative for any central nervous system disorders. The patient was in the fifth grade, lived at home with his parents, and had two healthy siblings. He was allergic to lamotrigine, which gave him a generalized rash. His vital signs were: temperature 97.5°, pulse 91 bpm, blood pressure 124/71 mm Hg, and weight 39.7 kg. Physical examination revealed no abnormal findings, and the neurologic examination was normal.

Advertisement

DIAGNOSIS

Ganglioglioma

Advertisement

IMAGING FINDINGS

Contrast-enhanced magnetic resonance imaging is the preferred imaging technique to diagnose ganglio-glioma, as it shows signal intensity on T1-weighted images, and high intensity on T2-weighted images. In the images in this case, the tumor presents as a well-defined cystic mass with a solid mural nodule (Figures 1 and 2). These tumors usually reveal iodine or gadolinium enhancement. On computed tomography, these tumors are well-circumscribed and peripherally located. Surrounding edema and hemorrhage is rarely seen. Most images are hypo- or isodense to brain parenchyma with poor contrast. Nuclear imaging and angiography are not helpful in diagnosis.

FIGURE 1.
FIGURE 1. Fluid-attenuated inversion recovery (FLAIR) image shows a hyperintense lesion in the medial temporal lobe near the brain stem.
FIGURE 2.
FIGURE 2. T2-weighted image reveals a high signal lesion in the same location.

Advertisement

DISCUSSION

Gangliogliomas are mixed-cell tumors containing both neural ganglionic and glial cell components. They occur often in patients <30 years of age and constitute 0.4% to 7.6% of all brain tumors and approximately 10% of all primary brain tumors in children.1 It has been difficult to assign such rare tumors to a particular category, as they comprise neuronal and glial precursors derived from the embryonic neuroepithelium. Although they are considered nonaggressive and are slow-growing, gangliogliomas can cause long-standing progressive symptoms that include seizures, symptoms of hydrocephalus, ataxia (if in cerebellum), and headaches.2 All imaging techniques are nonspecific, but they aid in the definition and localization of the tumor. Therefore, diagnosis is typically established histologically.3

This particular patient had a right craniotomy and resection of the tumor. Histopathology of the brain lesion was found to be a low-grade ganglioglioma (Figure 3). The prognosis is usually excellent if these tumors are fully resected.

FIGURE 3.
FIGURE 3. Hematoxylin and eosin stained section (40 × magnification) showing binucleate ganglion cell (arrow) and other neoplastic ganglion cells in a loose background. Nissl staining is obvious in neuronal cytoplasm (arrowheads).

CONCLUSION

Although gangliogliomas are rare in the differential diagnosis of intracranial masses, they should be considered in the presence of a well-defined cystic mass in the temporal lobes or cerebellum.

References

  1. Shin J, Lee H, Khang S. Neuronal tumors of the central nervous system: Radiologic findings and pathologic correlation. RadioGraphics. 2002;22:1177-1189.
  2. Castillo M, Davis P, Takei Y. Intracranial ganglioglioma: MR, CT, and clinical findings in 18 patients. AJNR Am J Neuroradiol. 1990;11:109-114.
  3. Krouwer H, Davis R, McDermott M. Gangliogliomas: A clinicopathological study of 25 cases and review of the literature. J Neurooncol. 1993;17:139-154.

Citation

Naseri I, Saini R, Welsh CT. RCOM RADIOLOGICAL CASE OF THE MONTH. Applied Radiology. 2004;33(3):48-49. doi:10.37549/AR1233.